167 results on '"Stephens, Tyler"'
Search Results
2. Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability
3. Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
4. A comparison of techniques to improve pulmonary EIT image resolution using a database of simulated EIT images
5. Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem
6. Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
7. Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
8. A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins
9. Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases
10. HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide
11. Vaccine elicitation and structural basis for antibody protection against alphaviruses
12. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses
13. Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants
14. SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
15. Structure-based design of stabilized recombinant influenza neuraminidase tetramers
16. Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base
17. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
18. Vaccine-elicited and naturally elicited antibodies differ in their recognition of the HIV-1 fusion peptide.
19. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
20. Kinetically Controlled Polyelectrolyte Complex Assembly of microRNA‐Peptide Nanoparticles toward Treating Mesothelioma
21. Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase
22. Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINs
23. A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies
24. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual
25. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies
26. Adaptation of a Commercial Qualitative BAX® Real-Time PCR Assay to Quantify Campylobacter spp. in Whole Bird Carcass Rinses
27. Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
28. Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses
29. Adaptation of a Commercial Qualitative BAX ® Real-Time PCR Assay to Quantify Campylobacter spp. in Whole Bird Carcass Rinses.
30. Genetic immunization with self-assembling SARS-CoV-2 Spike-HBsAg nanoparticles
31. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization
32. Development and Verification of a Poultry Management Tool to Quantify Salmonella from Live to Final Product Utilizing RT-PCR
33. A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins
34. Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition
35. The Drosophila model system to study tau action
36. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
37. Prefusion-Stabilized Lassa Virus Trimer Identifies Neutralizing Nanobodies and Reveals an Apex-Situated Site of Vulnerability
38. Application of a Commercial Salmonella Real-Time PCR Assay for the Detection and Quantitation of Salmonella enterica in Poultry Ceca
39. Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses
40. Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants
41. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
42. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
43. Structure-based design of stabilized recombinant influenza neuraminidase tetramers
44. Global Food Safety Issues
45. Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria
46. Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants
47. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
48. Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
49. Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains
50. A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.